Rybelsus R1 vs. R2: Which One Should You Take First?

Novo Nordisk recently introduced another formulation of Rybelsus designed for better absorption. While both manage blood sugar in type 2 diabetes, they differ in tablet strengths, bioavailability, and dosing. This article explains how each version works, how they compare, and what to consider if you’re switching between them or starting treatment for the first time.

Understanding Rybelsus Formulations

Rybelsus R1 is the original formulation and comes in tablet strengths of 3 mg, 7 mg, and 14 mg. The typical dosing schedule involves:

• • Initiation Phase (Days 1-30): 3 mg once daily
  • Escalation & Maintenance Dosage (Days 31-60): Increase to 7 mg once daily
  • Additional Glycemic Control (Day 61 and beyond): Depending on glycemic response, maintain at 7 mg or increase to 14 mg once daily

This stepwise approach helps minimize gastrointestinal side effects and allows your body to adjust to the medication.

In December 2024, Novo Nordisk introduced Rybelsus R2, a new formulation designed to enhance drug absorption, allowing for effective glycemic control at lower doses. The available tablet strengths are 1.5 mg, 4 mg, and 9 mg. The dosing schedule typically follows:

• • Initiation Phase (Days 1-30): 1.5 mg once daily
  • Escalation & Maintenance Dosage (Days 31-60): Increase to 4 mg once daily
  • Additional Glycemic Control (Day 61 and beyond): Depending on glycemic response, maintain at 4 mg or increase to 9 mg once daily

What Prompted the Development of Rybelsus R2?

Peptide-based drugs taken by mouth, like Rybelsus, tend to degrade quickly in the digestive tract, making them hard for the body to absorb. To address this issue, a newer version of Rybelsus (referred to as R2) was developed. This updated formulation enhances absorption, allowing for lower doses to be used without sacrificing effectiveness.

According to a 2024 bioequivalence trial, the newer Rybelsus tablets deliver the same safety and glucose-lowering benefits as the older strengths.

Data from clinical studies suggest the first-generation version (R1) has a bioavailability of approximately 0.4% to 1% when taken orally. The newer R2 formulation improves on this, with a bioavailability range of 1% to 2%. This enhanced absorption means lower doses of R2 can produce comparable therapeutic results.

Currently, there hasn’t been an official launch of the new dose options in the US market. However, the updated US prescribing information already includes these revised strengths, suggesting they’ve likely received FDA approval but haven’t yet reached pharmacy shelves.

Choosing Between Rybelsus R1 vs. R2

Both formulations are effective in managing type 2 diabetes, but the newer R2 formulation may offer advantages in terms of lower dosing and potentially improved tolerability due to its enhanced absorption profile.

The Rybelsus R2 formulation is taken using the same instructions as the original. It should be taken first thing in the morning on an empty stomach, using no more than 4 ounces of plain water. After swallowing the tablet whole, without chewing, breaking, or crushing it, you should wait at least 30 minutes before consuming any food, beverages, or other medications.

Switching Between Rybelsus Formulations

You should not switch between formulations during the first 30 days of Rybelsus treatment. After completing this initial period, a switch can be made if necessary. To transition, stop taking your current version and begin the new one the next day.

Dose equivalents when changing formulations:

Note that R1 and R2 are not dose-equivalent on a milligram basis. They cannot be swapped directly without following proper conversion. Only one formulation should be used at a time, either R1 or R2, not both.

Transitioning from Ozempic to Rybelsus

According to current prescribing guidance, the only established switch from Ozempic to Rybelsus is for those on Ozempic 0.5 mg injected once weekly. There are no standardized recommendations for transitioning from 0.25 mg, 1 mg, or 2 mg doses of Ozempic.

If you are moving from Ozempic 0.5 mg to oral Rybelsus, wait seven days after your last Ozempic dose before starting Rybelsus. Your starting dose depends on which Rybelsus version you’re using:

• • Rybelsus R1: Begin with 7 mg or 14 mg daily
  • Rybelsus R2: Begin with 4 mg or 9 mg daily

For other Ozempic doses, it’s best to consult your healthcare provider for a personalized switch plan.

Wrap-up

Rybelsus now comes in two formulations, R1 and the newer R2, each offering effective blood sugar control for individuals with type 2 diabetes. While both are effective at lowering blood sugar, R2 achieves similar results with lower doses thanks to better bioavailability.

You’ll follow a step-by-step dosing schedule with either version, but they aren’t equal in strength, so you can’t switch between them without adjusting your dose. Always talk to your healthcare provider before making any changes.

Frequently Asked Questions